Bionpharma Inc. recalls Atovaquone Oral Suspension
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
- Products
-
- Atovaquone Oral Suspension
- Company
- Bionpharma Inc.
- Where it was sold
-
Nationwide in the U.S.A.
Nationwide
- Units affected
- 1,980 bottles
- About this recall
- Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.